Dynavax Technologies Cash on Hand 2010-2025 | DVAX

Dynavax Technologies cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Dynavax Technologies Annual Cash on Hand
(Millions of US $)
2024 $714
2023 $742
2022 $624
2021 $546
2020 $165
2019 $151
2018 $146
2017 $192
2016 $81
2015 $196
2014 $123
2013 $189
2012 $125
2011 $114
2010 $72
2009 $37
Dynavax Technologies Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $661
2024-12-31 $714
2024-09-30 $764
2024-06-30 $736
2024-03-31 $724
2023-12-31 $742
2023-09-30 $720
2023-06-30 $682
2023-03-31 $652
2022-12-31 $624
2022-09-30 $586
2022-06-30 $518
2022-03-31 $503
2021-12-31 $546
2021-09-30 $414
2021-06-30 $346
2021-03-31 $233
2020-12-31 $165
2020-09-30 $177
2020-06-30 $201
2020-03-31 $130
2019-12-31 $151
2019-09-30 $175
2019-06-30 $140
2019-03-31 $183
2018-12-31 $146
2018-09-30 $180
2018-06-30 $216
2018-03-31 $251
2017-12-31 $192
2017-09-30 $192
2017-06-30 $127
2017-03-31 $85
2016-12-31 $81
2016-09-30 $110
2016-06-30 $139
2016-03-31 $167
2015-12-31 $196
2015-09-30 $221
2015-06-30 $93
2015-03-31 $98
2014-12-31 $123
2014-09-30 $131
2014-06-30 $154
2014-03-31 $178
2013-12-31 $189
2013-09-30 $76
2013-06-30 $89
2013-03-31 $105
2012-12-31 $125
2012-09-30 $148
2012-06-30 $160
2012-03-31 $107
2011-12-31 $114
2011-09-30 $53
2011-06-30 $62
2011-03-31 $53
2010-12-31 $72
2010-09-30 $48
2010-06-30 $58
2010-03-31 $31
2009-12-31 $37
2009-09-30 $47
2009-06-30 $54
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.265B $0.277B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $245.535B 17.91
Amgen (AMGN) United States $159.608B 13.59
Gilead Sciences (GILD) United States $146.874B 15.29
Vertex Pharmaceuticals (VRTX) United States $100.708B 25.96
Bristol Myers Squibb (BMY) United States $98.597B 7.20
CSL (CSLLY) Australia $85.086B 0.00
GSK (GSK) United Kingdom $80.262B 9.33
Regeneron Pharmaceuticals (REGN) United States $61.516B 14.97
Alnylam Pharmaceuticals (ALNY) United States $58.843B 0.00
Argenex SE (ARGX) Netherlands $40.014B 70.38
BioNTech SE (BNTX) Germany $27.290B 0.00
Insmed (INSM) United States $27.014B 0.00
Royalty Pharma (RPRX) United States $20.437B 8.28
Biogen (BIIB) United States $20.321B 8.66
Incyte (INCY) United States $16.973B 21.62
Illumina (ILMN) United States $15.387B 24.06
Genmab (GNMSF) Denmark $15.349B 13.59
Genmab (GMAB) Denmark $14.954B 13.63
Ascendis Pharma (ASND) Denmark $12.127B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.049B 15.59
QIAGEN (QGEN) Netherlands $10.970B 21.03
Moderna (MRNA) United States $10.902B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.313B 22.81
Exelixis (EXEL) United States $10.313B 18.60
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.962B 0.00
Exact Sciences (EXAS) United States $8.633B 0.00
Bio-Techne Corp (TECH) United States $8.403B 30.98
Roivant Sciences (ROIV) United Kingdom $8.056B 0.00
Halozyme Therapeutics (HALO) United States $7.868B 13.84
Guardant Health (GH) United States $7.343B 0.00
Anbio Biotechnology (NNNN) Germany $7.325B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.144B 38.11
Repligen (RGEN) United States $6.995B 76.29
Legend Biotech (LEGN) United States $6.891B 0.00
Revolution Medicines (RVMD) United States $6.789B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Rhythm Pharmaceuticals (RYTM) United States $6.483B 0.00
Avidity Biosciences (RNA) United States $5.979B 0.00
Nuvalent (NUVL) United States $5.460B 0.00
Axsome Therapeutics (AXSM) United States $5.450B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.432B 0.00
Abivax SA (ABVX) France $5.321B 0.00
Merus (MRUS) Netherlands $5.086B 0.00
Alkermes (ALKS) Ireland $4.796B 13.33
Cytokinetics (CYTK) United States $4.627B 0.00
Viking Therapeutics (VKTX) United States $4.501B 0.00
TG Therapeutics (TGTX) United States $4.455B 75.89
Krystal Biotech (KRYS) United States $4.349B 30.54
ACADIA Pharmaceuticals (ACAD) United States $4.273B 39.58
Vaxcyte (PCVX) United States $4.245B 0.00
Ascentage Pharma Group - (AAPG) China $4.183B 0.00
Arcellx (ACLX) United States $4.108B 0.00
Zealand Pharma (ZLDPF) Denmark $4.084B 4.04
ADMA Biologics Inc (ADMA) United States $4.054B 29.29
Zai Lab (ZLAB) United States $3.969B 0.00
Akero Therapeutics (AKRO) United States $3.950B 0.00
Telix Pharmaceuticals (TLX) Australia $3.905B 0.00
PTC Therapeutics (PTCT) United States $3.878B 6.44
Apellis Pharmaceuticals (APLS) United States $3.505B 0.00
Protagonist Therapeutics (PTGX) United States $3.488B 80.10
MoonLake Immunotherapeutics (MLTX) Switzerland $3.482B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.413B 0.00
Jyong Biotech (MENS) Taiwan $3.401B 0.00
Metsera (MTSR) United States $3.271B 0.00
Kymera Therapeutics (KYMR) United States $3.048B 0.00
Scholar Rock Holding (SRRK) United States $3.019B 0.00
Ligand Pharmaceuticals (LGND) United States $2.961B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.948B 0.00
Bavarian Nordic (BVNRY) Denmark $2.926B 15.46
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.869B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.861B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.836B 0.00
Immunovant (IMVT) United States $2.653B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.474B 834.50
Alvotech (ALVO) Luxembourg $2.419B 18.24
ImmunityBio (IBRX) United States $2.410B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.345B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.288B 0.00
Amicus Therapeutics (FOLD) United States $2.281B 0.00
Liquidia Technologies (LQDA) United States $2.234B 0.00
Agios Pharmaceuticals (AGIO) United States $2.150B 0.00
Denali Therapeutics (DNLI) United States $2.149B 0.00
IDEAYA Biosciences (IDYA) United States $2.132B 0.00
Sarepta Therapeutics (SRPT) United States $2.131B 0.00
Belite Bio (BLTE) United States $2.121B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.121B 11.89
Mesoblast (MESO) Australia $2.080B 0.00
Disc Medicine (IRON) United States $2.073B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.025B 0.00
Celcuity (CELC) United States $2.015B 0.00
Adaptive Biotechnologies (ADPT) United States $1.986B 0.00
CG Oncology (CGON) United States $1.960B 0.00
ANI Pharmaceuticals (ANIP) United States $1.898B 17.02
Vericel (VCEL) United States $1.831B 302.33
Beam Therapeutics (BEAM) United States $1.803B 0.00
Certara (CERT) United States $1.770B 32.41
Apogee Therapeutics (APGE) United States $1.719B 0.00
Twist Bioscience (TWST) United States $1.697B 0.00
Celldex Therapeutics (CLDX) United States $1.693B 0.00
Travere Therapeutics (TVTX) United States $1.678B 0.00
Biohaven (BHVN) United States $1.662B 0.00
Cidara Therapeutics (CDTX) United States $1.654B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.652B 0.00
Novavax (NVAX) United States $1.556B 4.20
WAVE Life Sciences (WVE) Singapore $1.553B 0.00
Viridian Therapeutics (VRDN) United States $1.514B 0.00
Janux Therapeutics (JANX) United States $1.509B 0.00
Edgewise Therapeutics (EWTX) United States $1.491B 0.00
Vera Therapeutics (VERA) United States $1.374B 0.00
AbCellera Biologics (ABCL) Canada $1.372B 0.00
89BIO (ETNB) United States $1.369B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.356B 0.00
Cogent Biosciences (COGT) United States $1.354B 0.00
NovoCure (NVCR) Jersey $1.311B 0.00
CureVac (CVAC) Germany $1.229B 5.96
Intellia Therapeutics (NTLA) United States $1.180B 0.00
GRAIL (GRAL) United States $1.169B 0.00
Pharvaris (PHVS) Netherlands $1.166B 0.00
Structure Therapeutics (GPCR) United States $1.159B 0.00
MannKind (MNKD) United States $1.144B 33.91
Pacira BioSciences (PCRX) United States $1.113B 11.80
Arcus Biosciences (RCUS) United States $1.106B 0.00
LENZ Therapeutics (LENZ) United States $1.080B 0.00
Zymeworks (ZYME) United States $1.079B 0.00
MiMedx (MDXG) United States $1.052B 23.70
Spyre Therapeutics (SYRE) United States $1.024B 0.00
Upstream Bio (UPB) United States $1.021B 0.00
Stoke Therapeutics (STOK) United States $0.998B 21.42
Praxis Precision Medicines (PRAX) United States $0.991B 0.00
CorMedix Inc (CRMD) United States $0.965B 17.24
Mineralys Therapeutics (MLYS) United States $0.963B 0.00
Oric Pharmaceuticals (ORIC) United States $0.938B 0.00
Nuvation Bio (NUVB) United States $0.936B 0.00
Geron (GERN) United States $0.925B 0.00
Iovance Biotherapeutics (IOVA) United States $0.923B 0.00
Sionna Therapeutics (SION) United States $0.919B 0.00
Trevi Therapeutics (TRVI) United States $0.916B 0.00
Urogen Pharma (URGN) United States $0.912B 0.00
Immunome (IMNM) United States $0.895B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
UniQure (QURE) Netherlands $0.888B 0.00
Precigen (PGEN) United States $0.876B 0.00
Anavex Life Sciences (AVXL) United States $0.854B 0.00
Nurix Therapeutics (NRIX) United States $0.809B 0.00
NeoGenomics (NEO) United States $0.802B 0.00
Niagen Bioscience (NAGE) United States $0.799B 77.08
Pharming Group (PHAR) Netherlands $0.798B 0.00
ArriVent BioPharma (AVBP) United States $0.792B 0.00
Sana Biotechnology (SANA) United States $0.792B 0.00
Gyre Therapeutics (GYRE) United States $0.784B 162.80
Oculis Holding AG (OCS) Switzerland $0.782B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.778B 0.00
Immatics (IMTX) Germany $0.769B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.764B 0.00
Tango Therapeutics (TNGX) United States $0.753B 0.00
BGM Group (BGM) China $0.736B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.731B 0.00
Fortrea Holdings (FTRE) United States $0.730B 12.97
Phathom Pharmaceuticals (PHAT) United States $0.726B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.712B 0.00
Zenas BioPharma (ZBIO) United States $0.708B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.691B 0.00
Dianthus Therapeutics (DNTH) United States $0.668B 0.00
GH Research (GHRS) Ireland $0.665B 0.00
MeiraGTx Holdings (MGTX) United States $0.657B 0.00
Arbutus Biopharma (ABUS) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Kura Oncology (KURA) United States $0.637B 0.00
Bicara Therapeutics (BCAX) United States $0.635B 0.00
Vir Biotechnology (VIR) United States $0.628B 0.00
Terns Pharmaceuticals (TERN) United States $0.617B 0.00
Maze Therapeutics (MAZE) United States $0.592B 0.00
Keros Therapeutics (KROS) United States $0.588B 46.71
Castle Biosciences (CSTL) United States $0.583B 57.40
Tyra Biosciences (TYRA) United States $0.570B 0.00
Rezolute (RZLT) United States $0.565B 0.00
AnaptysBio (ANAB) United States $0.564B 0.00
Kodiak Sciences (KOD) United States $0.558B 0.00
Rapport Therapeutics (RAPP) United States $0.537B 0.00
Myriad Genetics (MYGN) United States $0.531B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.529B 0.00
Opthea (OPT) Australia $0.525B 0.00
Palvella Therapeutics (PVLA) United States $0.523B 0.00
Septerna (SEPN) United States $0.523B 0.00
Arvinas (ARVN) United States $0.521B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.515B 0.00
Cytek Biosciences (CTKB) United States $0.510B 0.00
Verastem (VSTM) United States $0.506B 0.00
MBX Biosciences (MBX) United States $0.494B 0.00
Prime Medicine (PRME) United States $0.480B 0.00
ATyr Pharma (ATYR) United States $0.480B 0.00
Solid Biosciences (SLDB) United States $0.476B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.474B 0.00
Emergent Biosolutions (EBS) United States $0.472B 3.86
Erasca (ERAS) United States $0.465B 0.00
Eton Pharmaceuticals (ETON) United States $0.457B 0.00
Cullinan Therapeutics (CGEM) United States $0.453B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 0.00
ITeos Therapeutics (ITOS) United States $0.447B 0.00
Gossamer Bio (GOSS) United States $0.446B 0.00
REGENXBIO (RGNX) United States $0.446B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Tectonic Therapeutic (TECX) United States $0.440B 0.00
Absci (ABSI) United States $0.438B 0.00
PureTech Health (PRTC) United States $0.435B 0.00
Replimune (REPL) United States $0.434B 0.00
Kamada (KMDA) Israel $0.423B 21.62
Aura Biosciences (AURA) United States $0.417B 0.00
Inventiva S.A (IVA) France $0.417B 0.00
Compass Therapeutics (CMPX) United States $0.411B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.405B 0.00
I-Mab (IMAB) United States $0.397B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.387B 0.00
Astria Therapeutics (ATXS) United States $0.387B 0.00
XOMA Royalty (XOMA) United States $0.379B 0.00
Olema Pharmaceuticals (OLMA) United States $0.378B 0.00
Fulcrum Therapeutics (FULC) United States $0.369B 0.00
Abeona Therapeutics (ABEO) United States $0.365B 7.75
Northwest Biotherapeutics (NWBO) United States $0.363B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.354B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.352B 0.00
Benitec Biopharma (BNTC) United States $0.342B 0.00
Inhibrx Biosciences (INBX) United States $0.338B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.329B 0.00
Amarin (AMRN) Ireland $0.324B 0.00
CytomX Therapeutics (CTMX) United States $0.315B 3.41
DiaMedica Therapeutics (DMAC) United States $0.312B 0.00
Ocugen (OCGN) United States $0.307B 0.00
Candel Therapeutics (CADL) United States $0.305B 0.00
Design Therapeutics (DSGN) United States $0.304B 0.00
Cartesian Therapeutics (RNAC) United States $0.295B 0.00
Bright Minds Biosciences (DRUG) United States $0.295B 0.00
Neurogene (NGNE) United States $0.293B 0.00
Humacyte (HUMA) United States $0.292B 0.00
Puma Biotechnology (PBYI) United States $0.289B 5.85
Monte Rosa Therapeutics (GLUE) United States $0.283B 12.72
Foghorn Therapeutics (FHTX) United States $0.282B 0.00
Atea Pharmaceuticals (AVIR) United States $0.278B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.277B 0.00
Lifecore Biomedical (LFCR) United States $0.276B 0.00
DBV Technologies S.A (DBVT) France $0.274B 0.00
Editas Medicine (EDIT) United States $0.272B 0.00
Codexis (CDXS) United States $0.272B 0.00
Vor Biopharma (VOR) $0.271B 0.00
Crescent Biopharma (CBIO) United States $0.270B 0.00
Annexon (ANNX) United States $0.268B 0.00
Neumora Therapeutics (NMRA) United States $0.264B 0.00
Alumis (ALMS) United States $0.258B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.258B 0.00
Prima BioMed (IMMP) Australia $0.254B 0.00
Alpha Teknova (TKNO) United States $0.251B 0.00
ScPharmaceuticals (SCPH) United States $0.245B 0.00
Allogene Therapeutics (ALLO) United States $0.244B 0.00
Sagimet Biosciences (SGMT) United States $0.235B 0.00
Aardvark Therapeutics (AARD) United States $0.234B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.230B 0.00
Alector (ALEC) United States $0.228B 0.00
Tvardi Therapeutics (TVRD) United States $0.225B 0.00
Monopar Therapeutics (MNPR) United States $0.220B 0.00
CARGO Therapeutics (CRGX) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.216B 0.00
AC Immune (ACIU) Switzerland $0.214B 0.00
Contineum Therapeutics (CTNM) United States $0.207B 0.00
Voyager Therapeutics (VYGR) United States $0.207B 0.00
Innate Pharma S.A (IPHA) France $0.202B 0.00
Ventyx Biosciences (VTYX) United States $0.202B 0.00
Entrada Therapeutics (TRDA) United States $0.200B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Rapt Therapeutics (RAPT) United States $0.194B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.191B 0.00
Tenaya Therapeutics (TNYA) United States $0.189B 0.00
EnGene Holdings (ENGN) Canada $0.188B 0.00
Instil Bio (TIL) United States $0.188B 0.00
Caribou Biosciences (CRBU) United States $0.184B 0.00
C4 Therapeutics (CCCC) United States $0.175B 0.00
Sangamo Therapeutics (SGMO) United States $0.175B 0.00
Tevogen Bio Holdings (TVGN) United States $0.174B 0.00
SELLAS Life Sciences (SLS) United States $0.172B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.171B 0.00
Actuate Therapeutics (ACTU) United States $0.166B 0.00
Nkarta (NKTX) United States $0.165B 0.00
Nuvectis Pharma (NVCT) United States $0.164B 0.00
BioAge Labs (BIOA) United States $0.163B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Cardiff Oncology (CRDF) United States $0.162B 0.00
Elicio Therapeutics (ELTX) United States $0.161B 0.00
Cellectis S.A (CLLS) France $0.158B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.157B 0.00
Black Diamond Therapeutics (BDTX) United States $0.157B 12.00
Cabaletta Bio (CABA) United States $0.156B 0.00
BioHarvest Sciences (BHST) Canada $0.153B 0.00
Kyverna Therapeutics (KYTX) United States $0.152B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Agenus (AGEN) United States $0.148B 0.00
Seres Therapeutics (MCRB) United States $0.146B 0.00
MaxCyte (MXCT) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.140B 0.00
Immuneering (IMRX) United States $0.137B 0.00
Genelux (GNLX) United States $0.134B 0.00
TuHURA Biosciences (HURA) United States $0.134B 0.00
Citius Oncology (CTOR) United States $0.132B 0.00
Climb Bio (CLYM) United States $0.129B 0.00
Alpha Cognition (ACOG) Canada $0.128B 0.00
Compugen (CGEN) Israel $0.128B 0.00
Anika Therapeutics (ANIK) United States $0.127B 0.00
Scilex Holding (SCLX) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.126B 0.00
Coherus Oncology (CHRS) United States $0.122B 0.00
Seer (SEER) United States $0.122B 0.00
BioStem Technologies (BSEM) $0.118B 6.18
Zentalis Pharmaceuticals (ZNTL) United States $0.115B 0.00
Connect Biopharma Holdings (CNTB) United States $0.114B 0.00
Zura Bio (ZURA) United States $0.114B 0.00
Cognition Therapeutics (CGTX) United States $0.113B 0.00
Skye Bioscience (SKYE) United States $0.109B 0.00
Spero Therapeutics (SPRO) United States $0.107B 0.00
Oncolytics Biotech (ONCY) Canada $0.105B 0.00
HilleVax (HLVX) United States $0.104B 0.00
23andMe Holding (MEHCQ) United States $0.104B 0.00
Biomea Fusion (BMEA) United States $0.103B 0.00
Coya Therapeutics (COYA) United States $0.103B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
VistaGen Therapeutics (VTGN) United States $0.102B 0.00
OKYO Pharma (OKYO) $0.100B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.099B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
XBiotech (XBIT) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.096B 0.00
Pliant Therapeutics (PLRX) United States $0.095B 0.00
CervoMed (CRVO) United States $0.094B 0.00
Entera Bio (ENTX) Israel $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.091B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Immunic (IMUX) United States $0.089B 0.00
Atara Biotherapeutics (ATRA) United States $0.086B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.086B 0.00
Alto Neuroscience (ANRO) United States $0.085B 0.00
Invivyd (IVVD) United States $0.085B 0.00
Celularity (CELU) United States $0.083B 0.00
Elutia (ELUT) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Adagene (ADAG) China $0.080B 0.00
Oncobiologics (OTLK) United States $0.079B 0.00
Forte Biosciences (FBRX) United States $0.076B 0.00
Whitehawk Therapeutics (WHWK) United States $0.075B 0.00
Sutro Biopharma (STRO) United States $0.074B 0.00
Opus Genetics (IRD) United States $0.072B 0.00
ZIVO Bioscience (ZIVO) United States $0.070B 0.00
Applied Therapeutics (APLT) United States $0.069B 0.00
Ovid Therapeutics (OVID) United States $0.069B 0.00
Inovio Pharmaceuticals (INO) United States $0.068B 0.00
Repare Therapeutics (RPTX) Canada $0.067B 0.00
INmune Bio (INMB) United States $0.067B 0.00
Artiva Biotherapeutics (ARTV) United States $0.067B 0.00
Immix Biopharma (IMMX) United States $0.065B 0.00
Quantum Biopharma (QNTM) Canada $0.065B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
TELA Bio (TELA) United States $0.063B 0.00
Adlai Nortye (ANL) Cayman Islands $0.062B 0.00
Earth Science Tech (ETST) United States $0.060B 0.00
Adverum Biotechnologies (ADVM) United States $0.060B 0.00
Werewolf Therapeutics (HOWL) United States $0.060B 0.00
MiNK Therapeutics (INKT) United States $0.059B 0.00
KALA BIO (KALA) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.058B 0.00
ImageneBio (IMA) United States $0.057B 0.00
ABVC BioPharma (ABVC) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
PDS Biotechnology (PDSB) United States $0.055B 0.00
Adicet Bio (ACET) United States $0.055B 0.00
Annovis Bio (ANVS) United States $0.053B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.050B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.049B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Aligos Therapeutics (ALGS) United States $0.047B 0.00
Jasper Therapeutics (JSPR) United States $0.047B 0.00
Alterity Therapeutics - (ATHE) Australia $0.047B 0.00
Kalaris Therapeutics (KLRS) United States $0.046B 0.00
Grace Therapeutics (GRCE) Canada $0.045B 0.00
180 Life Sciences (ATNF) United States $0.043B 0.00
Generation Bio (GBIO) United States $0.042B 0.00
PepGen (PEPG) United States $0.042B 0.00
Exicure (XCUR) United States $0.042B 0.00
Renovaro (RENB) United States $0.041B 0.00
Equillium (EQ) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Senti Biosciences (SNTI) United States $0.040B 0.00
Pluri (PLUR) Israel $0.039B 0.00
Radiopharm Theranostics - (RADX) Australia $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Mersana Therapeutics (MRSN) United States $0.036B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
ALX Oncology Holdings (ALXO) United States $0.035B 0.00
OnKure Therapeutics (OKUR) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
CAMP4 Therapeutics (CAMP) United States $0.034B 0.00
Clearside Biomedical (CLSD) United States $0.033B 0.00
BioXcel Therapeutics (BTAI) United States $0.033B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.032B 0.00
Clene (CLNN) United States $0.030B 0.00
AN2 Therapeutics (ANTX) United States $0.029B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.029B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
Dyadic (DYAI) United States $0.027B 0.00
Medicus Pharma (MDCX) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Rallybio (RLYB) United States $0.025B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.025B 0.00
Q32 Bio (QTTB) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Femasys (FEMY) United States $0.023B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Curis (CRIS) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Passage Bio (PASG) United States $0.022B 0.00
BioAtla (BCAB) United States $0.022B 0.00
Cingulate (CING) United States $0.021B 0.00
Moleculin Biotech (MBRX) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Dare Bioscience (DARE) United States $0.020B 0.00
Aytu BioPharma (AYTU) United States $0.020B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Chemomab Therapeutics (CMMB) Israel $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
X4 Pharmaceuticals (XFOR) United States $0.017B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
LakeShore Biopharma (LSB) China $0.016B 0.00
Abpro Holdings (ABP) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.015B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Intensity Therapeutics (INTS) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.013B 0.00
Gelteq (GELS) Australia $0.013B 0.00
IBio (IBIO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Synaptogenix (TAOX) United States $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Leap Therapeutics (LPTX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IN8bio (INAB) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Portage Biotech (PRTG) $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Apollomics (APLM) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Tharimmune (THAR) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00